Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient
Lipid-rich breast carcinoma (LRBC) is rare cancer considered to be a variant of invasive ductal breast carcinoma. It is characterized by an aggressive behavior and poor prognosis and requires prompt recognition and close follow-up. The tumor derives its name from the intracytoplasmic neutral lipid t...
Saved in:
Main Authors: | Deepika Sirohi, M.D (Author), Kent Swimley (Author), Amanda L. Profit, M.D (Author), Nicole D. Riddle, M.D (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma
by: Silvia Pelligra, et al.
Published: (2020) -
Expression of Her-2/neu in extrahepatic cholangiocarcinoma
by: Shamekh R, et al.
Published: (2017) -
Quantitative mast cell analysis and hormone receptor study (ER, PR and HER2/neu) in invasive carcinoma of breast
by: Rama D Pyla, et al.
Published: (2020) -
Expression of HER2/neu in gastric adenocarcinoma and its correlation with serum HER2/neu level and E-cadherin expression
by: Ishan Pandey, et al.
Published: (2022) -
Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)
by: Alessandro D. Santin, et al.
Published: (2017)